(NP (NP (NP (VBN Induced) (JJ myeloid) (NN differentiation)) (PP (IN of) (NP (NN K562) (NNS cells))) (PP (IN with) (NP (NP (NN downregulation)) (PP (IN of) (NP (ADJP-COOD (ADJP (JJ erythroid)) (CC and) (ADJP (JJ megakaryocytic))) (NN transcription) (NNS factors))))) (: :)) (NP (NP (DT a) (JJ novel) (JJ experimental) (NN model)) (PP (IN for) (NP (JJ hemopoietic) (NN lineage) (NN restriction))) (. .)))
(S (NP-SBJ-28 (DT The) (JJ human) (NN erythroleukemia) (NN cell) (NN line) (NN K562)) (VP (MD can) (VP (VB be) (VP (VBN induced) (S (NP-SBJ (-NONE- *-28)) (VP (TO to) (VP (VB differentiate) (PP (IN along) (NP (DT the) (ADJP-COOD (ADJP (JJ erythroid)) (CC and) (ADJP (JJ megakaryocytic))) (NNS lineages))))))))) (. .))
(S (ADVP (RB Here)) (NP-SBJ (PRP we)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP-SBJ (NP (NN hexamethylene) (NN bisacetamide)) (PRN (-LRB- -LRB-) (NP (NN HMBA)) (-RRB- -RRB-))) (VP (VBD induced) (S (NP-SBJ (NN K562) (NNS cells)) (VP (TO to) (VP (VB differentiate) (PP (IN along) (NP (DT a) (JJ third) (NN pathway)))))))))) (. .))
(S (NP-SBJ-29 (DT This)) (VP (VBD was) (VP (VBN accompanied) (NP (-NONE- *-29)) (PP (IN by) (NP-LGS (NP (NN downregulation)) (PP (IN of) (NP (NP (CD two) (NN transcription) (NNS factors)) (VP (ADVP (RB normally)) (VBN expressed) (NP (-NONE- *)) (PP (IN in) (NP (ADJP-COOD (ADJP (JJ erythroid)) (, ,) (ADJP (NN mast)) (CC and) (ADJP (NN megakaryocyte))) (NNS lineages)))))))))) (. .))
(S (NP-SBJ (NN Northern) (NN analysis)) (VP (VBD demonstrated) (NP (NP (JJ coordinate) (NN downregulation)) (PP (IN of) (NP-COOD (NP (NN alpha) (NN globin)) (CC and) (NP (NN gamma) (NN globin)) (CONJP (IN in) (NN addition) (TO to)) (NP (NP (DT the) (CD two) (JJ lineage-restricted) (NN transcription) (NNS factors)) (, ,) (NP-COOD (NP (NN SCL)) (CC and) (NP (NN GATA-1)))))))) (. .))
(S (NP-SBJ-30 (NP (NN Proliferation)) (PP (IN of) (NP (DT the) (NN K562) (NNS cells)))) (VP (VBD was) (ADVP (RB also)) (VP (VBN suppressed) (NP (-NONE- *-30)))) (. .))
(S (NP-SBJ (JJ Clonal) (NN assay)) (VP (VBD showed) (SBAR (IN that) (S (NP-SBJ (DT the) (NN suppression)) (VP-COOD (VP (VBD was) (ADJP-PRD (JJ irreversible))) (CC and) (VP (VBD appeared) (ADJP-PRD (JJ analogous) (PP (TO to) (NP (NP (DT the) (NN commitment)) (PP (IN of) (NP (NP (NP (JJ murine) (NN erythroleukemia)) (PRN (-LRB- -LRB-) (NP (NN MEL)) (-RRB- -RRB-))) (NNS cells))) (PP (TO to) (NP (JJ terminal) (NN differentiation))))))))))) (. .))
(S (PP (IN In) (NN contrast) (TO to) (NP (NN MEL) (NNS cells))) (, ,) (ADVP (RB however)) (, ,) (NP-SBJ (NN K562) (NNS cells)) (VP-COOD (VP (VBD acquired) (NP (DT a) (JJ macrophage-like) (NN morphology))) (CC and) (VP (VBD exhibited) (NP (DT a) (JJ complete) (NN failure) (S (NP-SBJ (-NONE- *)) (VP (TO to) (VP (VB generate) (NP (JJ benzidine-positive) (NNS cells)))))))) (. .))
(S (NP-SBJ (NN Electron) (NN microscopy)) (VP (VBD revealed) (NP (NP (DT a) (JJ marked) (NN increase)) (PP (IN in) (NP (NP (NNS granules)) (VP (VBG resembling) (NP (NP (DT those)) (ADJP (JJ specific) (PP (IN for) (NP (NNS eosinophils)))))))))) (. .))
(S (NP-SBJ (NN Surface) (NN marker) (NN analysis)) (VP (VBD showed) (SBAR (IN that) (S (NP-SBJ (JJ HMBA-induced) (NNS cells)) (VP (VBD expressed) (NP (NP (VBN reduced) (NNS levels)) (PP (IN of) (NP-COOD (NP (NN glycophorin) (NN A)) (, ,) (NP (NN CD5)) (, ,) (NP (NN CD7)) (CC and) (NP (NN CD11b))))))))) (. .))
(S (NP-SBJ (NP (DT No) (NN upregulation)) (PP (IN of) (NP (ADJP-COOD (ADJP (NN megakaryocyte)) (CC or) (ADJP (JJ lymphoid))) (NNS markers)))) (VP (VBD occurred)) (. .))
(S (ADVP (RB Thus)) (NP-SBJ (NP (DT the) (NN response)) (PP (IN of) (NP (NN K562) (NNS cells))) (PP (TO to) (NP (NN HMBA)))) (VP (MD may) (VP (VB provide) (NP (NP (DT a) (JJ useful) (JJ experimental) (NN system)) (PP (IN for) (S (NP-SBJ (-NONE- *)) (VP (VBG studying) (NP (NP (DT the) (JJ molecular) (NNS mechanisms)) (ADJP (JJ responsible) (PP (IN for) (NP (NP (NN downmodulation)) (PP (IN of) (NP (JJ lineage-restricted) (NN transcription) (NNS factors))) (PP-TMP (IN during) (NP (JJ hemopoietic) (NN lineage) (NN commitment))))))))))))) (. .))
